Veracyte Ownership | Who Owns Veracyte?

Overview Forecast RevenueFinancials Chart Transcripts

Veracyte Ownership Summary

Veracyte is owned by 113.16% institutional investors, 0.54% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.96% of VCYT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.04% of its assets in Veracyte shares.

VCYT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Veracyte	113.16%	0.54%	-13.70%
Sector	Healthcare Stocks	50.59%	12.40%	37.01%
Industry	Diagnostics & Research Stocks	78.38%	9.48%	12.14%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	13.49M	16.96%	$792.06M
Vanguard group	8.50M	10.80%	$358.02M
Blackrock	7.79M	10.42%	$168.88M
Fmr	7.70M	9.68%	$452.38M
Artisan partners limited partnership	5.54M	6.96%	$325.27M
State street	4.70M	5.91%	$275.95M
Vanguard capital management	3.59M	4.52%	$211.07M
Dimensional fund advisors lp	2.83M	3.55%	$166.01M
First trust advisors lp	2.51M	3.15%	$147.29M
Ark investment management	2.30M	2.89%	$134.84M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Palisades investment partners	175.03K	2.92%	$10.28M
Perkins capital management	59.96K	2.65%	$3.52M
Summit creek advisors	118.96K	2.38%	$6.99M
Iron triangle partners lp	485.00K	2.37%	$16.65M
Silverarc capital management	318.00K	1.94%	$18.68M
Brown capital management	96.02K	1.13%	$5.64M
Arrowmark colorado	441.99K	1.08%	$25.96M
Oberweis asset management inc/	877.73K	1.07%	$51.55M
Efg asset management (north america)	219.98K	0.98%	$7.56M
Ark investment management	2.30M	0.88%	$134.84M

Top Buyers

Holder	Shares	% Assets	Change
Driehaus capital management	1.05M	0.36%	1.05M
Sixth street partners management company	939.98K	0.01%	939.98K
Artemis investment management llp	638.93K	0.33%	638.93K
Blackrock	7.79M	0.00%	581.69K
Iron triangle partners lp	485.00K	2.37%	485.00K

Top Sellers

Holder	Shares	% Assets	Change
Arrowmark colorado	441.99K	1.08%	-932.12K
Ark investment management	2.30M	0.88%	-757.87K
Fiera capital	-	-	-625.54K
Deerfield management company, l.p. (series c)	101.00K	0.06%	-625.00K
Eventide asset management	-	-	-570.72K

New Positions

Holder	Shares	% Assets	Change	Value
Sixth street partners management company	939.98K	0.01%	939.98K	$55.21M
Artemis investment management llp	638.93K	0.33%	638.93K	$37.52M
Iron triangle partners lp	485.00K	2.37%	485.00K	$16.65M
Uss investment management	319.88K	0.07%	319.88K	$18.78M
Freestone grove partners lp	299.91K	0.11%	299.91K	$17.61M

Sold Out

Holder	Change
Strategic advocates	-2.00
Cedar mountain advisors	-3.00
Vermillion wealth management	-3.00
Global financial private client	-5.00
Kohmann bosshard financial services	-6.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	375	10.29%	90,003,451	1.95%	113	0.90%	204	5.15%	124	24.00%
Mar 31, 2026	165	-50.45%	22,106,368	-74.49%	28	0.23%	85	-51.70%	57	-49.56%
Dec 31, 2025	226	-24.16%	56,376,420	-37.19%	71	0.54%	121	-27.11%	77	-11.49%
Sep 30, 2025	283	5.99%	88,589,496	7.86%	113	1.03%	161	21.97%	83	-15.31%
Jun 30, 2025	273	-5.21%	85,426,396	1.00%	109	0.93%	138	1.47%	98	-8.41%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	4.86M	6.04%	-3.94K
Vanguard Morn Total Stk Mkt Idx Investor	2.53M	3.17%	8.88K
Vanguard Total Stock Mkt Idx Inv	2.53M	3.17%	8.88K
Vanguard MStar Total Stk Mkt Idx Invest	2.54M	3.16%	8.80K
Vanguard US Total Market Shares ETF	2.46M	3.16%	2.69K
iShares Russell 2000 ETF	2.05M	2.55%	-36.38K
Vanguard Small Cap Index	1.83M	2.28%	4.76K
First Trust NYSE Arca Biotech ETF	1.60M	2.00%	-14.58K
State Street® SPDR® S&P® Biotech ETF	1.47M	1.83%	3.37K
SPDR® S&P Biotech ETF	1.33M	1.69%	2.96K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 18, 2026	EASTHAM KARIN	-	Sell	$168.91K
Jun 18, 2026	EASTHAM KARIN	-	Sell	$28.33K
Jun 04, 2026	McGuire Annie	EVP, General Counsel	Sell	$89.01K
Jun 04, 2026	McGuire Annie	EVP, General Counsel	Sell	$69.03K
Jun 04, 2026	Chambers Rebecca	Chief Financial Officer	Sell	$98.23K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	10
2026 Q1	-	8
2025 Q4	-	32
2025 Q3	-	2
2025 Q2	-	3

VCYT Ownership FAQ

Who Owns Veracyte?

Veracyte shareholders are primarily institutional investors at 113.16%, followed by 0.54% insiders and -13.70% retail investors. The average institutional ownership in Veracyte's industry, Diagnostics & Research Stocks, is 78.38%, which Veracyte exceeds.

Who owns the most shares of Veracyte?

Veracyte’s largest shareholders are Blackrock funding, inc. /de (13.49M shares, 16.96%), Vanguard group (8.5M shares, 10.80%), and Blackrock (7.79M shares, 10.42%). Together, they hold 38.18% of Veracyte’s total shares outstanding.

Does Blackrock own Veracyte?

Yes, BlackRock owns 10.42% of Veracyte, totaling 7.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 168.88M$. In the last quarter, BlackRock increased its holdings by 581.69K shares, a 8.07% change.

Who is Veracyte’s biggest shareholder by percentage of total assets invested?

Palisades investment partners is Veracyte’s biggest shareholder by percentage of total assets invested, with 2.92% of its assets in 175.03K Veracyte shares, valued at 10.28M$.

Who is the top mutual fund holder of Veracyte shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Veracyte shares, with 6.04% of its total shares outstanding invested in 4.86M Veracyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools